FDA Drug Application (202123) for COMPLERA by GILEAD SCIENCES INC

Back to FDA Applications sponsored by GILEAD SCIENCES INC

Application Number202123
Product Number001
FormTABLET;ORAL
Dosage200MG;EQ 25MG BASE;300MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCOMPLERA
Active IngredientEMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE

Active IngredientCount
List of drugs with Active Ingredient EMTRICITABINE12
List of drugs with Active Ingredient RILPIVIRINE HYDROCHLORIDE3
List of drugs with Active Ingredient TENOFOVIR DISOPROXIL FUMARATE15


Back to FDA Applications sponsored by GILEAD SCIENCES INC